nucleic
acid
protein
glycoconjug
play
critic
role
number
import
signal
transduct
pathway
develop
rapid
effici
autom
platform
synthesi
nucleic
acid
peptid
monomer
build
block
figur
b
led
better
understand
fundament
interact
biomolecul
play
import
biolog
process
result
field
genom
proteom
grown
exponenti
develop
new
therapeut
strategi
diseas
prevent
treatment
recent
lack
gener
access
approach
construct
oligosaccharid
meant
special
research
laboratori
capabl
access
defin
glycoconjug
slow
pace
research
area
turn
understand
divers
role
compound
natur
major
challeng
develop
gener
access
approach
synthesi
oligosaccharid
inher
reaction
product
linear
phosphodiest
amid
bond
linkag
requir
nucleic
acid
peptid
synthesi
easier
gener
individu
build
block
lack
signific
steric
hindranc
newli
form
bond
nonstereogen
contrast
synthesi
oligosaccharid
linear
branch
often
involv
steric
encumb
build
block
newli
form
bond
part
stereogen
center
order
use
reaction
must
gener
desir
linkag
high
select
develop
firstgener
autom
solidphas
oligosaccharid
synthes
seeberg
cowork
led
first
report
autom
synthesi
three
linear
mannan
oligosaccharid
branch
phytoalexin
elicitor
bglucan
figur
synthesi
glycoconjug
play
import
role
immun
respons
pathogen
fungi
candida
albican
began
would
becom
new
chapter
prepar
glycoconjug
biolog
evalu
sinc
autom
proven
vastli
benefici
addit
bacteri
antigen
cancer
antigen
vaccin
candid
nlink
core
oligosaccharid
glycoconjug
rapidli
synthes
use
autom
moreov
glycoconjug
synthes
scale
would
imposs
use
standard
solutionphas
synthet
techniqu
goal
chapter
review
histor
aspect
solidphas
oligosaccharid
synthesi
well
recent
develop
includ
engin
advanc
recent
led
design
fulli
autom
platform
new
improv
chemistri
broaden
scope
reaction
use
autom
autom
solidphas
synthesi
sever
carbohydr
construct
includ
bacteri
viral
antigen
cancer
antigen
vaccin
candid
nlink
core
oligosaccharid
also
present
autom
solidphas
oligosaccharid
synthesi
use
autom
synthes
make
glycosid
linkag
analog
process
way
dna
synthes
gener
phosphodiest
linkag
peptid
synthes
gener
peptid
linkag
gener
process
illustr
figur
select
function
monosaccharid
build
block
contain
temporari
perman
protect
group
commonli
refer
donor
serv
electrophil
ad
sequenti
grow
oligosaccharid
chain
serv
nucleophil
acceptor
acceptor
connect
via
inert
linker
solid
support
gener
insolubl
organ
solvent
glycosid
linkag
made
activ
appropri
function
monosaccharid
build
block
donor
presenc
grow
nucleophil
oligosaccharid
acceptor
coupl
two
molecul
glycosyl
reaction
grow
oligosaccharid
wash
appropri
temporari
protect
group
remov
expos
next
function
group
coupl
process
repeat
desir
oligosaccharid
synthes
oligosaccharid
remov
solid
support
purifi
necessari
remain
temporari
perman
protect
group
remov
oligosaccharid
function
studi
key
featur
autom
process
shown
figur
includ
autom
platform
insolubl
solid
support
inert
linker
select
function
carbohydr
build
block
contain
temporari
perman
protect
group
develop
area
signific
impact
evolut
autom
solidphas
oligosaccharid
synthesi
first
autom
synthet
platform
autom
solidphas
oligosaccharid
synthesi
develop
seeberg
cowork
base
modifi
appli
biosystem
peptid
synthes
abi
system
chosen
prototyp
afford
commerci
avail
could
accommod
nine
differ
reagentsbuild
block
one
time
requir
minim
modif
name
custom
made
jacket
reaction
vessel
connect
variabl
cryostat
allow
control
cool
reaction
mixtur
prototyp
abi
synthes
play
critic
role
develop
autom
oligosaccharid
synthesi
synthes
reliabl
solvent
deliveri
wast
remov
rel
effici
addit
reaction
mix
achiev
agit
reaction
vessel
effect
produc
uniform
heterogen
solut
howev
instrument
design
peptid
synthesi
sever
shortcom
reagent
deliveri
achiev
via
solenoid
valv
imprecis
therefor
deliveri
small
reagent
volum
deliveri
reagent
control
deliveri
rate
difficult
achiev
addit
system
could
modifi
accommod
addit
reagent
limit
number
differ
glycosyl
reaction
could
perform
singl
run
final
temperatur
control
requir
manual
adjust
cryostat
therefor
necessit
continu
presenc
oper
reason
seeberg
group
focus
effort
develop
new
fulli
autom
solidphas
oligosaccharid
synthes
order
provid
effici
platform
autom
solidphas
oligosaccharid
synthesi
seeberg
cowork
collabor
ancora
pharmaceut
develop
first
fulli
autom
solidphas
oligosaccharid
synthes
new
design
introduc
address
shortcom
modifi
abi
peptid
synthes
syring
pump
technolog
precis
reagent
deliveri
combin
solenoid
valv
rapid
pressuredriven
wash
step
system
also
includ
vessel
capabl
deliv
reagent
build
block
one
time
addit
mechan
control
design
serv
interfac
instrument
person
comput
provid
full
control
system
includ
temperatur
modul
instrument
capabl
reach
temperatur
low
via
adjust
cryostat
high
via
heat
block
demchenko
cowork
recent
report
first
modifi
hplc
autom
solidphas
oligosaccharid
synthesi
experiment
setup
includ
unmodifi
threehead
pump
hplc
system
onboard
variabl
rang
uv
detector
use
standard
chromatographi
column
pack
preswel
polym
resin
benefit
system
employ
commerci
avail
hplc
found
almost
synthet
analyt
laboratori
program
accomplish
use
standard
hplc
oper
softwar
demchenko
hplcbase
solidphas
oligosaccharid
synthes
first
autom
system
use
realtim
uvvi
reaction
monitor
show
signific
promis
emerg
technolog
howev
one
signific
disadvantag
limit
number
reagentsbuild
block
system
accommod
without
signific
modif
continu
presenc
oper
commerci
avail
nonsolubl
polystyren
solid
support
merrifield
resin
tentagel
figur
commonli
employ
autom
solidphas
oligosaccharid
synthesi
resin
gener
exhibit
high
load
chemic
inert
reaction
condit
requir
glycosyl
easili
filter
reaction
solut
disadvantag
requir
swell
expos
reactiv
site
resin
incomplet
swell
lead
incomplet
reaction
delet
sequenc
control
pore
glass
cpg
rigid
mechan
robust
materi
shrink
swell
presenc
solvent
use
high
success
synthesi
oligonucleotid
howev
attract
much
attent
autom
oligosaccharid
synthesi
two
major
reason
first
cpg
load
approxim
mmol
g
gener
lower
merrifield
tentagel
mmol
g
second
grow
oligosaccharid
shown
eventu
block
glass
pore
reduc
diffus
reagent
reactiv
site
cpg
larger
pore
size
use
success
although
resin
tend
significantli
fragil
major
autom
solidphas
oligosaccharid
synthes
report
date
made
use
merrifield
resin
chloromethyl
polystyren
resin
wide
employ
peptid
synthesi
addit
high
load
merrifield
resin
rel
inert
acid
basic
condit
use
autom
process
one
signific
disadvantag
comparison
cpg
use
dna
synthesi
number
wash
step
requir
complet
remov
excess
reagent
byproduct
porou
polystyren
matrix
addit
reactiv
site
resin
expos
presenc
swell
solvent
dichloromethan
tetrahydrofuran
toluen
prohibit
use
nonswel
solvent
hexan
methanol
tentagel
also
use
autom
solidphas
synthesi
oligosaccharid
tentagel
consist
polyethylen
glycol
crosslink
polystyren
via
ether
linkag
tentagel
combin
benefit
solubl
polyethylen
glycol
support
insolubl
handl
characterist
polystyren
bead
tentagel
also
display
rel
uniform
swell
varieti
solvent
medium
high
polar
rang
toluen
water
one
signific
disadvantag
comparison
merrifield
resin
hydrophil
natur
resin
make
remov
residu
water
difficult
lead
reduc
yield
glycosyl
linker
connect
first
unit
grow
oligosaccharid
chain
solid
support
effect
linker
must
remain
intact
synthesi
select
cleavabl
rel
mild
condit
end
synthesi
optim
cleav
linker
function
handl
attach
protein
carrier
chip
surfac
date
four
linker
commonli
employ
autom
oligosaccharid
synthesi
figur
alkenediol
octenediol
butenediol
linker
bifunct
linker
succinam
linker
merrifi
octenediol
butenediol
linker
contain
singl
doubl
bond
fit
requir
suitabl
linker
autom
solidphas
oligosaccharid
synthesi
linker
gener
connect
solid
support
via
ether
ester
linkag
synthesi
linker
cleav
crossmetathesi
base
hydrolysi
crossmetathesi
use
grubb
firstgener
catalyst
grubb
presenc
ethylen
result
fulli
protect
npentenyl
glycosid
octenediol
allyl
glycosid
butenediol
hydrolyz
free
reduc
sugar
activ
glycosyl
carboncarbon
doubl
bond
also
modifi
produc
handl
nucleophil
suitabl
conjug
three
major
disadvantag
use
octenediol
butenediol
linker
first
alken
prohibit
use
electrophil
requir
activ
thioglycosid
autom
process
second
grubb
catalyst
requir
cleavag
resin
expens
often
difficult
remov
final
reaction
product
final
alken
handl
requir
function
use
conjug
biolog
evalu
transform
reduc
overal
yield
final
oligosaccharid
product
bifunct
linker
prepar
address
issu
associ
octenediol
butenediol
linker
bifunct
linker
connect
solid
support
via
ester
linkag
fulli
compat
common
glycosyl
condit
includ
electrophil
condit
requir
activ
thioglycosid
cleavag
ester
use
basecatalyz
hydrolysi
inexpens
accomplish
mild
condit
purif
hydrogenolysi
remain
carbam
reveal
linker
termin
amin
suitabl
conjug
main
disadvantag
bifunct
linker
use
limit
type
temporari
protect
group
use
acet
group
longer
serv
temporari
protect
group
sinc
reaction
condit
requir
remov
would
also
result
cleavag
oligosaccharid
resin
succinam
linker
recent
report
use
autom
solidphas
oligosaccharid
synthesi
linker
connect
solid
support
tentagel
via
amid
linkag
also
cleav
use
basecatalyz
hydrolysi
succinam
linker
offer
similar
advantag
bifunct
linker
principl
could
support
electrophil
condit
requir
thioglycosid
activ
main
disadvantag
succinam
linker
alcohol
handl
produc
hydrolysi
resin
must
function
conjug
identif
synthesi
build
block
requir
construct
oligosaccharid
labori
timeconsum
task
autom
process
protect
group
pattern
must
design
achiev
desir
connect
stereoselect
high
yield
addit
natur
protect
group
directli
influenc
reactiv
build
block
affect
reaction
time
yield
basic
featur
build
block
highlight
figur
includ
anomer
leav
group
lg
particip
group
linkag
nonparticip
group
linkag
posit
r
temporari
protect
group
stabl
glycosyl
condit
readili
remov
next
glycosyl
reaction
r
perman
protect
group
remain
intact
final
global
deprotect
step
r
mammalian
carbohydr
commonli
compris
ten
monosaccharid
glucos
galactos
mannos
sialic
acid
nacetlyglucosamin
nacetylgalactosamin
fucos
glucuron
acid
iduron
acid
xylos
figur
principl
carbohydr
residu
link
differ
function
group
linkag
gener
new
stereocent
potenti
divers
signific
exampl
number
theoret
structur
possibl
hexasaccharid
compris
one
ten
mammalian
monosaccharid
approxim
billion
estim
build
block
would
requir
assembl
given
mammalian
oligosaccharid
howev
recent
studi
suggest
build
block
would
requir
access
approxim
known
mammalian
oligosaccharid
due
signific
overlap
common
connect
thirti
build
block
shown
figur
rank
rel
abund
mammalian
oligosaccharid
type
ii
lewi
blood
group
oligosaccharid
le
le
x
nonasaccharid
provid
good
exampl
number
type
carbohydr
linkag
made
illustr
figur
le
le
x
molecul
compris
four
blink
sugar
residu
glucos
galactos
nacetylglucosamin
fucos
individu
differ
connect
four
sugar
requir
five
differenti
function
build
block
figur
would
requir
synthes
le
le
x
molecul
autom
solidphas
oligosaccharid
synthesi
monoor
disaccharid
lg
serv
glycosyl
donor
electrophil
activ
presenc
nucleophil
three
common
lg
employ
autom
solidphas
oligosaccharid
synthesi
figur
phosphat
imid
thiol
histor
glycosyl
phosphat
imid
play
import
role
autom
solidphas
oligosaccharid
synthesi
howev
number
autom
solidphas
oligosaccharid
synthes
employ
thioglycosid
report
recent
literatur
accept
mechan
glycosid
bond
format
use
glycosyl
phosphat
imidi
thiol
standard
glycosyl
condit
illustr
scheme
nucleophil
displac
n
result
glycosid
bond
posit
play
role
result
stereochemistri
product
reason
stereochemistri
lg
gener
littl
impact
stereochem
outcom
reaction
howev
demonstr
case
anom
may
differ
chemic
properti
result
enhanc
reduc
reactiv
glycosyl
phosphat
synthes
lactol
glycosyl
bromid
acet
trichloracetimid
nitrat
thioglycosid
glycosid
glycal
oxazolin
dibutylphosph
commonli
employ
autom
solidphas
oligosaccharid
synthesi
gener
activ
stoichiometr
amount
lewi
acid
often
trimethylsilyl
trifluoromethanesulfon
tmsotf
temperatur
approxim
presenc
nucleophil
scheme
glycosyl
imid
gener
prepar
correspond
lactol
gener
glycosyl
imid
advantag
comparison
glycosyl
phosphat
condit
requir
activ
catalyt
tmsotf
trifluoromethanesulfon
acid
tfoh
gener
milder
glycosyl
trichloroacetimid
nphenyl
trifluoroacetimid
gener
activ
temperatur
scheme
glycosyl
phosphat
imid
shown
reason
stabl
year
lg
leav
group
r
particip
nonparticip
group
temporari
perman
r
temporari
protect
group
r
perman
protect
group
lg
phosphat
imid
nphenyl
trifluoroacetimid
lg
build
block
requir
synthesi
approxim
known
mammalian
oligosaccharid
lg
scheme
activ
condit
glycosyl
phosphat
imid
thioglycosid
recent
thioglycosid
shown
effect
lg
autom
oligosaccharid
synthesi
thioglycosid
prepar
number
sourc
common
includ
lactol
glycosyl
halid
peracetyl
sugar
autom
solidphas
oligosaccharid
synthesi
thioglycosid
activ
use
either
niodosuccinimid
ni
tmsotf
nistfoh
promot
system
scheme
temperatur
approxim
major
advantag
use
thioglycosid
autom
solidphas
oligosaccharid
synthesi
shelf
stabil
gener
remain
stabl
even
room
temperatur
extend
period
addit
thioglycosid
use
access
donor
phosphat
access
directli
thioglycosid
thioglycosid
hydrolyz
lactol
convert
imid
two
step
temporari
protect
group
carboxymethyl
fmoc
levulinoyl
lev
silylprotect
group
scheme
proven
effect
temporari
protect
group
autom
group
gener
instal
use
fmoccl
presenc
pyridin
high
yield
autom
solidphas
oligosaccharid
synthesi
fmoc
group
readili
remov
treatment
solut
piperidin
dimethyl
formamid
dmf
give
fulven
byproduct
use
monitor
progress
reaction
free
alcohol
serv
nucleophil
next
glycosyl
reaction
scheme
lg
scheme
effect
posit
glycosyl
levulinoyl
lev
ester
group
gener
instal
use
levulin
acid
n
n
dicyclohexylcarbodiimid
dcc
dimethylaminopyridin
dmap
room
temperatur
lev
group
gener
remov
autom
solidphas
oligosaccharid
synthesi
use
mol
l
solut
hydrazin
mixtur
pyridin
acet
acid
give
desir
alcohol
scheme
condit
affect
normal
ester
acet
benzoat
pivalo
although
less
common
silylprotect
group
gain
import
autom
solidphas
oligosaccharid
synthesi
commonli
employ
silylprotect
group
tertbutyldimethylsilyl
ether
tb
tbdm
commonli
instal
use
tbdmscl
imidazol
dmf
remov
tbdm
group
autom
accomplish
use
tetrabutyl
ammonium
fluorid
give
free
alcohol
scheme
perman
protect
group
use
autom
solidphas
oligosaccharid
synthesi
includ
benzyl
group
bn
pivaloyl
piv
benzoyl
bz
ester
azid
n
ntrichloroacetyl
tca
group
scheme
group
gener
remov
newli
oligosaccharid
cleav
resin
purifi
benzyl
group
bn
common
perman
protect
group
use
autom
due
stabil
rel
acid
basic
condit
gener
instal
via
treatment
correspond
alcohol
benzyl
bromid
sodium
hydrid
dmf
remov
use
standard
hydrogenolysi
scheme
azid
n
gener
employ
nonparticip
protect
group
synthesi
sugar
azid
commonli
introduc
nucleophil
substitut
sugar
deriv
tosyl
mesyl
epoxid
azid
also
instal
treat
correspond
amino
sugar
sodium
azid
triflic
anhydrid
triflat
azid
copper
sulfat
azid
commonli
reduc
hydrogenolyisi
correspond
amin
scheme
pivaloyl
piv
benzoyl
bz
ester
ntrichloroacetamid
tca
stabl
acet
hydrolyz
readili
standard
reaction
condit
use
autom
solidphas
oligosaccharid
synthesi
group
gener
prepar
treat
free
alcohol
piv
bz
amin
tca
correspond
acyl
chlorid
presenc
base
piv
bz
group
readili
hydrolyz
treatment
strong
base
ntrichloroacetyl
tca
group
gener
reduc
correspond
nacetyl
group
use
tributyltin
hydrid
reflux
xylen
acetyl
ester
ac
serv
temporari
perman
protect
group
depend
linker
chosen
autom
acet
commonli
prepar
treatment
free
alcohol
acet
anhydrid
pyridin
hydrolyz
use
solut
sodium
methoxid
methanol
condit
octenediol
butenediol
inker
unaffect
condit
bifunct
succinam
linker
readili
cleav
linker
employ
acet
serv
perman
protect
group
lg
scheme
temporari
protect
group
deprotect
strategi
natur
protect
group
also
affect
gener
reactiv
profil
individu
monosaccharid
regard
glycosyl
donor
electrondon
group
stabil
acyloxoniumoxocarbenium
ion
intermedi
donat
electron
densiti
intermedi
via
induct
group
tend
enhanc
rate
glycosyl
reaction
contrast
electronwithdraw
group
destabil
acyloxoniumoxocarbenium
ion
intermedi
withdraw
electron
densiti
reactiv
site
affect
decreas
reaction
rate
extrem
case
imped
reactiv
altogeth
stabil
destabil
base
electron
donat
withdraw
known
armeddisarm
concept
electrondon
group
arm
donor
wherea
electronwithdraw
group
disarm
donor
consid
electron
glycosyl
acceptor
electrondon
group
near
nucleophil
hydroxyl
group
may
enhanc
nucleophil
lead
faster
reaction
rate
electronwithdraw
group
near
nucleophil
hydroxyl
group
remov
electron
densiti
induct
diminish
overal
rate
reaction
first
autom
solidphas
oligosaccharid
synthes
report
seeberg
cowork
began
revolut
prepar
glycoconjug
biolog
evalu
sinc
initi
report
autom
use
scientist
around
lg
scheme
perman
protect
group
deprotect
strategi
world
synthes
complex
oligosaccharid
includ
bacteri
antigen
cancer
antigen
vaccin
candid
nlink
core
oligosaccharid
synthes
sever
oligosaccharid
present
section
exampl
chosen
histor
purpos
well
highlight
challeng
complex
oligosaccharid
prepar
use
autom
solidphas
oligosaccharid
process
major
oligosaccharid
synthes
via
autom
oligosaccharid
synthes
synthes
use
either
firstor
secondgener
autom
solidphas
oligosaccharid
synthes
case
merrifi
resin
use
solidsupport
glycosyl
reaction
typic
employ
doublecoupl
figur
tripl
coupl
strategi
involv
activ
equival
glycosyl
donor
two
three
time
wash
step
remov
unreact
donor
reaction
byproduct
process
employ
ensur
complet
reaction
therebi
minim
delet
sequenc
neg
impact
purif
desir
oligosaccharid
amannan
bglucan
known
play
import
role
pathogenesi
certain
fungi
first
autom
solidphas
oligosaccharid
synthes
amannan
bglucan
oligosaccharid
report
seeberg
cowork
use
firstgener
autom
solidphas
oligosaccharid
synthes
synthes
compound
provid
proof
principl
linear
branch
oligosaccharid
could
made
autom
high
yield
use
standard
lg
glycosyl
imid
phosphat
synthesi
link
penta
hepta
decaamannan
accomplish
use
firstgener
solidphas
oligosaccharid
synthes
octenediolfunction
merrifield
resin
repeatedli
glycosyl
mannosyl
imid
use
doubl
coupl
approach
equival
per
cycl
presenc
catalyt
amount
tmsotf
scheme
ac
serv
direct
group
anchimer
assist
temporari
protect
group
could
hydrolyz
condit
pentasaccharid
n
gener
yield
demonstr
approxim
coupl
effici
step
heptasaccharid
n
decasaccharid
n
produc
yield
respect
demonstr
approxim
coupl
effici
step
two
select
function
glucos
build
block
use
gener
phytoalexin
elicitor
bglucan
scheme
first
exampl
branch
glycan
synthes
autom
solidphas
oligosaccharid
synthesi
octenediolfunction
merrifield
resin
coupl
two
glycosyl
phosphat
build
block
monosaccharid
disaccharid
contain
piv
particip
group
iter
doubl
coupl
requir
equival
desir
phosphat
build
block
stoichiometr
amount
tmsotf
glycosyl
lev
ester
grow
oligosaccharid
chain
remov
use
hydrazinepyridineacet
acid
solut
furnish
nucleophil
next
glycosyl
reaction
four
glycosyl
reaction
oligosaccharid
cleav
resin
use
grubb
catalyst
ethylen
atmospher
produc
final
protect
phytoalexin
elicitor
bglucan
yield
five
step
leishmania
transmit
human
via
sand
fli
affect
million
peopl
worldwid
autom
solidphas
oligosaccharid
synthesi
use
synthes
tetrasaccharid
cap
antigen
glycosylphosphatidylinositol
gpi
found
surfac
leishmania
parasit
provid
first
exampl
autom
solidphas
synthesi
branch
glycan
use
function
monosaccharid
build
block
differ
lg
octenediolfunction
merrifield
resin
three
build
block
scheme
contain
particip
group
employ
synthesi
tetrasaccharid
cap
mannosyl
imid
glycosyl
linker
use
catalyt
amount
tmsotf
remov
lev
group
use
hydrazin
follow
glycosyl
galactosyl
phosphat
use
stoichiometr
amount
tmsotf
gave
desir
disaccharid
hydrolysi
ac
condit
follow
glycosyl
mannosyl
imid
gave
desir
trisaccharid
second
hydrolysi
glycosyl
follow
cleavag
grubb
catalyst
ethylen
atmospher
gave
desir
tetrasaccharid
yield
approxim
coupl
effici
step
malaria
caus
parasit
plasmodium
transmit
mosquito
approxim
million
case
malaria
record
worldwid
death
report
data
obtain
world
health
organ
gpi
toxin
respons
pathogenesi
parasit
identifi
target
vaccin
develop
shortli
thereaft
first
autom
solidphas
synthesi
report
four
select
function
imid
build
block
requir
synthesi
scheme
use
acet
temporari
protect
group
need
instal
second
mannos
residu
posit
reduc
sugar
requir
imid
nonparticip
group
employ
synthesi
glycosyl
mannosyl
imid
octenediolfunction
merrifield
resin
use
doubl
coupl
strategi
stoichiometr
amount
tmsotf
led
mixtur
b
anom
mixtur
inconsequenti
sinc
later
step
synthesi
vaccin
candid
requir
hydrolysi
pentenyl
tether
refunction
reduc
sugar
methanolysi
ac
correspond
hydroxyl
group
use
condit
provid
correspond
nucleophil
requir
extens
subsequ
glycosylationhydrolysi
cycl
imid
gave
final
tetrasaccharid
yield
cleavag
resin
approxim
coupl
effici
step
worth
note
employ
build
block
repres
first
use
silylprotect
group
autom
oligosaccharid
synthesi
report
initi
solutionphas
screen
led
use
glucosylamin
phosphat
build
block
function
particip
phthalimido
group
nphth
temporari
lev
group
doubl
coupl
strategi
employ
firstgener
autom
solidphas
oligosaccharid
synthes
glycosyl
first
build
block
octenediolfunction
merrifield
resin
follow
remov
lev
protect
group
use
hydrazinepyridineacet
acid
solut
gave
free
hydroxi
methyl
group
extens
two
addit
glycosylationdeprotect
step
requir
access
final
trisaccharid
yield
coupl
effici
cleavag
resin
use
grubb
catalyst
presenc
ethylen
scheme
lower
yield
like
due
steric
hindranc
conform
constraint
particip
phthalimido
group
develop
bifunct
linker
secondgener
autom
solidphas
oligosaccharid
synthes
permit
use
thioglycosid
autom
synthesi
b
oligoglucosamin
scheme
synthesi
doubl
coupl
strategi
employ
activ
glucosylamin
thioglycosid
function
trichloroacetamid
tca
particip
group
amin
fmoc
group
promot
system
consist
niodosuccinimid
ni
triflic
acid
tfoh
presenc
bifunct
linker
led
initi
monosaccharid
bifunct
linkerfunction
resin
hydrolysi
fmoc
group
use
solut
piperdin
dmf
provid
free
alcohol
extens
subsequ
glycosylationdeprotect
cycl
follow
basemedi
hydrolysi
resin
reduct
tca
group
led
product
hexasaccharid
five
addit
cycl
dodecasaccharid
addit
cycl
yield
coupl
effici
yield
close
coupl
effici
respect
synthesi
indic
mark
improv
initi
trisaccharid
synthesi
scheme
similar
strategi
employ
thioglycosid
build
block
particip
tca
group
fmoc
group
use
synthes
b
yield
shown
reduc
yield
b
hexasaccharid
presum
due
increas
steric
encumbr
nucleophil
core
nlink
glycan
nlink
glycan
play
critic
role
cellcel
recognit
commun
mammal
nlink
glycan
also
implic
tumor
progress
metastasi
pathogenesi
virus
hiv
ebola
coronavirus
pentasaccharid
core
nlink
glycan
consist
chitobios
two
b
link
glucosamin
residu
follow
branch
b
link
mannos
residu
present
signific
challeng
due
b
mannosid
linkag
chitobios
disaccharid
first
autom
solidphas
synthesi
core
nlink
glycan
seeberg
cowork
employ
firstgener
autom
solidphas
oligosaccharid
synthes
octenediolfunction
merrifield
resin
doubl
coupl
strategi
use
three
select
function
imid
scheme
reduc
glucosamin
residu
core
chitobios
disaccharid
instal
use
imid
donor
function
particip
tca
group
amin
temporari
ac
protect
group
standard
condit
hydrolysi
ac
use
condit
provid
nucleophil
subsequ
glycosyl
synthesi
instal
difficult
bmannosid
linkag
avoid
use
disaccharid
build
block
particip
tca
group
posit
temporari
acet
group
posit
hydrolysi
acet
follow
doubl
glycosyl
mannosyl
imid
gave
core
pentasaccharid
yield
approxim
coupl
effici
cleavag
resin
use
grubb
catalyst
develop
secondgener
solidphas
oligosaccharid
synthes
bifunct
linker
advanc
synthesi
bmannosid
linkag
encourag
seeberg
cowork
revisit
synthesi
nlink
glycan
new
approach
illustr
scheme
chitobios
core
instal
use
doubl
coupl
strategi
glucosylamin
thioglyosid
build
block
function
tca
particip
group
amin
temporari
fmoc
group
two
glycosyl
cycl
perform
use
nistfoh
promot
system
remov
fmoc
group
accomplish
cycl
use
piperidin
expos
next
acceptor
bmannosid
linkag
form
use
mannosyl
ocb
build
block
consist
nonparticip
benzyl
posit
temporari
benzyliden
acet
instal
posit
temporari
silylprotect
group
posit
mark
first
use
benzyliden
acet
ocb
donor
autom
glycosyl
chitobios
disaccharid
use
triflic
anhydrid
tf
dtbmp
follow
remov
silyl
ether
tbaf
select
ring
open
benzylidien
acet
use
diboran
dibutylboron
triflat
bu
botf
gave
core
nlink
trisaccharid
underw
subsequ
glycosyl
mannosyl
imid
final
assembl
core
nlink
glycan
complet
yield
cleavag
resin
condit
bmannosid
linkag
instal
ab
ratio
although
yield
far
lower
origin
synthesi
core
nlink
glycan
work
repres
first
exampl
direct
gener
betamannosid
linkag
use
autom
solidphas
platform
cancer
antigen
glycosphingolipid
scheme
globoh
scheme
interest
vaccin
develop
addit
recent
shown
play
role
hiv
infect
globoh
synthes
record
time
use
autom
solidphas
approach
employ
firstgener
autom
oligosaccharid
synthes
ci
agalactosid
linkag
link
axial
hydroxyl
group
second
galactos
residu
common
motif
glycan
present
signific
challeng
solut
autom
care
screen
determin
galactosyl
imid
galactosyl
phosphat
globoh
contain
nonparticip
benzyl
group
could
use
select
instal
linkag
effici
protect
oligosaccharid
subsequ
assembl
use
octenediolfunction
merrifield
resin
standard
glycosyl
condit
function
monosaccharid
use
synthes
trisaccharid
scheme
yield
coupl
effici
globoh
hexasaccharid
synthes
build
block
build
block
h
scheme
yield
coupl
effici
per
step
develop
secondgener
autom
solidphas
oligosaccharid
synthes
bifunct
linker
led
first
autom
synthesi
iso
scheme
glycan
biolog
interest
due
homolog
synthesi
iso
mark
first
autom
solidphas
oligosaccharid
synthesi
use
doubl
coupl
strategi
employ
differenti
function
thioglycosid
build
block
first
glucos
residu
instal
glycosyl
glucosyl
thioglycosid
build
block
function
perman
particip
piv
group
temporari
fmoc
group
bifunct
linkerfunction
merrifield
resin
use
nistfoh
promot
system
hydrolysi
fmoc
group
use
piperdin
subsequ
glycosylationdeprotect
cycl
first
galactosyl
thioglycosid
build
block
particip
pivalo
protect
group
temporari
fmoc
group
follow
glycosyl
galactosyl
thioglycosid
build
block
nonparticip
bn
group
provid
desir
glycan
yield
yield
coupl
effici
cleavag
resin
use
condit
instal
nonreduc
termin
galactos
build
block
repres
greatest
challeng
type
ii
lewi
blood
group
oligosaccharid
le
hexasaccharid
le
le
x
nonasaccharid
interest
potenti
cancer
vaccin
complex
includ
number
differ
type
carbohydr
residu
challeng
linkag
render
signific
challeng
autom
solidphas
oligosaccharid
synthesi
first
autom
synthesi
le
le
le
x
employ
firstgener
autom
oligosaccharid
synthes
esterlink
octenediolfunction
linker
five
differenti
function
phosphat
build
block
standard
glycosyl
condit
fmoc
lev
group
use
temporari
protect
group
wherea
piv
tca
group
use
direct
group
except
galactos
build
block
use
fmoc
group
temporari
protect
direct
group
fucos
build
block
requir
nonparticip
group
instal
desir
ci
linkag
synthesi
le
shown
scheme
success
doubl
coupl
build
block
gave
desir
hexasaccharid
yield
cleavag
resin
use
condit
doubl
coupl
fmoc
lev
protect
group
remov
use
piperdin
hydrazin
respect
le
le
x
nonasaccharid
synthes
use
similar
protocol
scheme
produc
desir
product
yield
cleavag
resin
sialic
acid
contain
glycan
mediat
pathogen
invas
modul
import
role
cellular
commun
despit
signific
chemic
synthesi
glycan
limit
challeng
instal
sialic
acid
residu
often
accomplish
low
yield
limit
select
autom
solidphas
oligosaccharid
synthesi
sialyl
lewi
x
sle
x
tetrasaccharid
involv
inflamm
metastasi
demonstr
sialic
acid
residu
could
instal
autom
secondgener
autom
oligosaccharid
synthes
bifunct
linkerfunction
merrifield
resin
doubl
coupl
strategi
employ
three
build
block
glucosylamin
thioglyosid
tca
particip
group
temporari
fmoc
lev
protect
group
disaccharid
imid
contain
acet
particip
group
fucosyl
imid
nonparticip
bn
group
requir
complet
synthesi
sle
x
yield
coupl
effici
key
success
synthesi
prepar
disaccharid
build
block
incorpor
sialic
acid
residu
method
appli
sever
sialyl
lactos
sialyl
lactosamin
deriv
excel
yield
scheme
hplcbase
autom
oligosaccharid
synthes
recent
employ
demchenko
cowork
gener
sever
b
link
oligosaccharid
initi
glucos
residu
contain
particip
bz
group
temporari
trityl
group
coupl
tentagel
resin
use
edc
dmap
column
detrityl
wet
tfa
expos
hyaluron
acid
glycosylaminoglycan
compos
repeat
unit
glucuron
acid
nacetylglucosamin
monosaccharid
hyaluron
acid
function
molecular
lubric
also
shown
play
import
role
inflammatori
respons
cell
prolifer
recognit
migrat
adhes
first
autom
solidphas
synthesi
welldefin
hyaluron
acid
employ
secondgener
autom
synthes
butenediolfunction
merrifield
resin
tripl
coupl
strategi
use
equival
two
ditertbutylsilylideneprotect
imid
build
block
scheme
incorpor
particip
group
tca
build
block
bz
build
block
lev
group
temporari
protect
group
activ
glucosylamin
imid
use
tfoh
demonstr
effici
tmsotf
follow
hydrolysi
lev
protect
group
hydrazin
iter
glycosyl
reaction
disaccharid
gave
desir
glycan
yield
n
crossmetathesi
resin
interestingli
author
demonstr
direct
glycosyl
disaccharid
linker
unsuccess
necessit
synthesi
build
block
addit
remov
glycan
resin
use
crossmetathesi
use
grubb
catalyst
prove
challeng
due
partial
dechlorin
tca
group
use
decoy
substrat
trichloracetamid
use
circumv
unwant
reaction
bmannuron
acid
algin
bmannuron
acid
algin
major
compon
cell
wall
alga
also
major
constitu
exopolysaccharid
pseudomona
aerigunosa
opportunist
nonsocomi
gramneg
bacterium
autom
synthesi
tetra
octa
dodecabmannuron
acid
algin
via
autom
solidphas
oligosaccharid
synthesi
recent
report
use
secondgener
autom
oligosaccharid
synthes
butenediolfunction
merrifi
resin
mannuron
imid
build
block
function
nonparticip
bn
temporari
lev
protect
group
scheme
major
challeng
synthesi
select
instal
bmannosid
residu
tfoh
found
effect
promot
reaction
found
complet
select
temperatur
near
decomposit
donor
glycosyl
cycl
requir
hydrolysi
lev
group
use
hydrazin
first
oligosaccharid
synthes
tetrasaccharid
prepar
use
four
glycosylationdeprotect
cycl
yield
approxim
coupl
effici
octasaccharid
dodecasaccharid
synthes
coupl
effici
step
provid
final
product
respect
oligoarabinofuranosid
first
autom
solidphas
oligosaccharid
synthesi
oligoarabinofuranosid
recent
report
oligoarabinofuranosid
analog
major
compon
mycobacteri
cell
envelop
play
import
role
number
critic
aspect
life
cycl
mycobacterium
versatil
secondgener
synthes
combin
use
bifunct
linker
provid
synthesi
seri
linear
branch
oliogarabinofuranosid
sequenti
doubl
coupl
two
thiofuranosid
contain
bz
particip
group
temporari
fmoc
protect
group
use
nistfoh
promot
system
shown
provid
best
yield
selectivit
piperdin
use
remov
fmoc
protect
group
coupl
cycl
overal
process
shown
effici
rapid
hexasaccharid
scheme
prepar
yield
coupl
effici
h
fulli
autom
solidphas
synthet
oligosaccharid
platform
new
linker
strategi
streamlin
access
host
carbohydr
construct
includ
bacteri
viral
antigen
cancer
antigen
vaccin
candid
nlink
oligosaccharid
led
increas
gener
underst
fundament
role
oligosaccharid
number
biolog
process
current
research
direct
identifi
monosaccharid
build
block
use
access
major
glycoconjug
class
includ
nlink
olink
glycolipid
glycosylaminoglycan
oligosaccharid
use
studi
import
carbohydrateprotein
carbohydratenucl
acid
carbohydratecarbohydr
interact
involv
normal
abnorm
cellular
process
develop
rapid
effici
synthet
protocol
commerci
build
block
next
critic
step
expand
autom
solidphas
platform
oligosaccharid
synthesi
